Conversion therapy for unresectable hepatocellular carcinoma: Advances and challenges

被引:0
|
作者
He, Yan-Fei [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 6, Dept Hlth Management Ctr, 6 Fucheng Rd, Beijing 100048, Peoples R China
关键词
Unresectable hepatocellular carcinoma; Conversion therapy; Challenges; Advances; Advanced hepatocellular carcinoma; Targeted therapy; Immunotherapy; PORTAL-VEIN LIGATION; RADIOFREQUENCY ABLATION; HEPATIC RESECTION; SORAFENIB; CHEMOTHERAPY; BEVACIZUMAB; COMBINATION; EFFICACY; PLUS;
D O I
10.4251/wjgo.v16.i10.4289
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recently, the World Journal of Gastrointestinal Oncology published an article entitled "Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of the literature", in which the authors shared their successful experience with complete surgical resection after multidisciplinary conversion therapy. The study by Chu et al demonstrates the great challenges that the advanced hepatocellular carcinoma (HCC) poses to surgical oncology, reveals the complexity of conversion therapy for unresectable HCC, emphasizes the important role of a multidisciplinary management model in conversion therapy, and enriches our understanding of the dynamics of personalized treatment for different patients. At present, conversion therapy is a hot research topic in the treatment of unresectable HCC, which has brought new hope to many patients with moderately advanced HCC. However, there are still many urgent problems to be solved in conversion therapy. Here, we would like to further discuss the advances and challenges of conversion therapy for unresectable HCC with the authors and the general readers.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Hepatocellular carcinoma: Advances in systemic therapy
    Abou-Alfa, Ghassan K.
    CANCER INVESTIGATION, 2007, 25 : 11 - 11
  • [22] Advances of Targeted Therapy for Hepatocellular Carcinoma
    Niu, Mengke
    Yi, Ming
    Li, Ning
    Wu, Kongju
    Wu, Kongming
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [23] Hepatocellular Carcinoma: Advances in Systemic Therapy
    Selene, Insija Ilyas
    Ozen, Merve
    Patel, Reema A.
    SEMINARS IN INTERVENTIONAL RADIOLOGY, 2024, 41 (01) : 56 - 62
  • [24] Radiation therapy for unresectable hepatocellular carcinoma with obstructive jaundice
    Suh, Y.
    Seong, J.
    Koom, W.
    Lee, I.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S279 - S279
  • [25] Percutaneous microwave coagulation therapy for unresectable hepatocellular carcinoma
    Ohmoto, K
    Miyake, I
    Tsuduki, M
    Shibata, N
    Takesue, M
    Kunieda, T
    Ohno, S
    Kuboki, M
    Yamamoto, S
    HEPATO-GASTROENTEROLOGY, 1999, 46 (29) : 2894 - 2900
  • [26] Proton Therapy Outcomes for Localized, Unresectable Hepatocellular Carcinoma
    Chadha, A. S.
    Gunther, J. R.
    Minsky, B. D.
    Taniguchi, C. M.
    Mahmood, U.
    Delclos, M. E.
    Suh, Y.
    Sawakuchi, G. O.
    Park, P. C.
    Beddar, S.
    Gupta, S.
    Kaur, H.
    Javle, M. M.
    Kaseb, A. O.
    Koay, E. J.
    Das, P.
    Crane, C. H.
    Krishnan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E181 - E182
  • [27] Potential Molecular Targeted Therapy for Unresectable Hepatocellular Carcinoma
    Kumar, Shashank
    Pandey, Abhay Kumar
    CURRENT ONCOLOGY, 2023, 30 (02) : 1363 - 1380
  • [28] Conversion therapy and suitable timing for subsequent salvage surgery for initially unresectable hepatocellular carcinoma: What is new?
    Ze-Feng Zhang
    Yu-Jun Luo
    Quan Lu
    Shi-Xue Dai
    Wei-Hong Sha
    World Journal of Clinical Cases, 2018, (09) : 259 - 273
  • [29] Conversion therapy and suitable timing for subsequent salvage surgery for initially unresectable hepatocellular carcinoma: What is new?
    Zhang, Ze-Feng
    Luo, Yu-Jun
    Lu, Quan
    Dai, Shi-Xue
    Sha, Wei-Hong
    WORLD JOURNAL OF CLINICAL CASES, 2018, 6 (09) : 259 - 273
  • [30] Inflammation-related nomogram for predicting survival of patients with unresectable hepatocellular carcinoma received conversion therapy
    Wu, Jia-Lin
    Luo, Jun-Yang
    Jiang, Zai-Bo
    Huang, Si-Bo
    Chen, Ge-Run
    Ran, Hui-Ying
    Liang, Qi-Yue
    Huang, Ming-Sheng
    Lai, Li-Sha
    Chen, Jun-Wei
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (20) : 3168 - +